ERBB2 and breast cancer: To our knowledge, this was the first study that overall discussed the impact of HR status on the clinical characteristics and prognostic profiles of HER2-positive breast cancer based on a large-scale cohort, of which the findings could provide promising evidence for introduction of treatment strategies in clinical practice.